你即將離開本站

並前往https://www.nejm.org/doi/full/10.1056/NEJMoa1910607

Use of CAR-Transduced Natural Killer Cells in CD19-Positive ...

Abstract Background Anti-CD19 chimeric antigen receptor (CAR) T-cell therapy has shown remarkable clinical efficacy in B-cell cancers.

確定！ 回上一頁

查詢 「Cells」的人也找了：

  1. cells中文
    2.
  2. Cells Impact Factor
    3.
  3. excel cells用法
    4.
  4. Cells Impact Factor 2019
    5.
  5. Cells Impact Factor 2021
    6.
  6. cells期刊
    7.
  7. Cell journal
    8.
  8. Cells journal
    9.